CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection

被引:18
作者
Damiani, D
Stocchi, R
Masolini, P
Michelutti, A
Geromin, A
Sperotto, A
Skert, C
Michieli, M
Baccarani, M
Fanin, R
机构
[1] Univ Hosp, Div Haematol, Dept Med & Morphol Res, Bone Marrow Transplant Unit, I-33100 Udine, Italy
[2] Ctr Riferimento Oncol, I-33081 Aviano, Italy
[3] Univ Hosp, Inst Haematol & Med Oncol L&A Seragnoli, Bologna, Italy
关键词
CD34+selection; infections; multiple myeloma; transplantation;
D O I
10.1093/annonc/mdg107
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Large-scale CD34+ enrichment has been demonstrated a safe method in autologous transplantation for multiple myeloma. However, the high CD34+ enrichment and the consequent plasma cell purging result in concomitant T-cell and dendritic-cell (DC) depletion, theoretically increasing the risk of life-threatening infections. Patients and methods: We evaluated immunological and dendritic reconstitution in 72 myeloma patients who had undergone CD34+-selected (n = 45) and unmanipulated (n = 27) stem cell transplant, and its correlation with infections. Results: Haematological recovery occurred promptly in all patients. Only a slight delay in platelet recovery to >50 x 10(9)/I was observed in patients receiving CD34+-enriched graft, Natural killer (NK) cell count recovered in all patients within 2 months and B-cell count had recovered by 6 months post-transplant in both groups. CD3 cells remained lower than normal in both groups. CD8 cells increased above the normal level, reaching a peak at day 90, and lowered to normal level within 1 year post-transplant. CD4 lymphocytes remained <50% of normal, especially in selected patients. In both groups, both DC1 and DC2 counts were already significantly lower than in normal individuals before conditioning therapy. Pre-conditioning levels of DC1 were reached in unmanipulated patients at day 30 and became normal at 6 months. In selected patients, DC1 pre-transplant level was observed at day 60 and was maintained thereafter. DC2 recovery showed a similar trend. In unselected patients, DC2 count increased to pre-conditioning level at haematological recovery and was normal after 1 year. In selected transplants, DC2 increased more slowly than DC1 in the same patients: pre-transplant level was detected at day 90 but was still significantly lower than normal 1 year after transplant. The incidence of infection was similar in both groups. Sepsis had Gram+ aetiology in the majority of cases. After engraftment only viral infections were recorded, mostly due to herpes reactivation, with no difference between groups. Discussion: In spite of a delay in immune recovery, CD34 enrichment is not associated with a significant increase of complications due to infection. Relatively fast NK cell recovery to pre-transplant levels and the presence of functionally efficient DCs can justify the low incidence of infections.
引用
收藏
页码:475 / 480
页数:6
相关论文
共 17 条
[1]   European group for blood and marrow transplantation registry studies in multiple myeloma [J].
Björkstrand, B .
SEMINARS IN HEMATOLOGY, 2001, 38 (03) :219-225
[2]  
Diviné M, 1999, BRIT J HAEMATOL, V105, P349, DOI 10.1046/j.1365-2141.1999.01344.x
[3]   Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery [J].
Dreger, P ;
Viehmann, K ;
von Neuhoff, N ;
Glaubitz, T ;
Petzoldt, O ;
Glass, B ;
Uharek, L ;
Rautenberg, P ;
Suttorp, M ;
Mills, B ;
Mitsky, P ;
Schmitz, N .
BONE MARROW TRANSPLANTATION, 1999, 24 (02) :153-161
[4]  
FEGAN C, 1995, BONE MARROW TRANSPL, V16, P277
[5]   Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation [J].
Friedman, J ;
Lazarus, HM ;
Koç, ON .
BONE MARROW TRANSPLANTATION, 2000, 26 (08) :831-836
[6]   Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation [J].
Galy, A ;
Rudraraju, S ;
Baynes, R ;
Klein, J .
BONE MARROW TRANSPLANTATION, 2000, 25 (12) :1249-1255
[7]   PURIFIED CD34(+) LIN(-) THY(+) STEM-CELLS DO NOT CONTAIN CLONAL MYELOMA CELLS [J].
GAZITT, Y ;
READING, CC ;
HOFFMAN, R ;
WICKREMA, A ;
VESOLE, DH ;
JAGANNATH, S ;
CONDINO, J ;
LEE, B ;
BARLOGIE, B ;
TRICOT, G .
BLOOD, 1995, 86 (01) :381-389
[8]   Flow cytometry evaluation of plasma cells contaminating leukapheresis pre- and post-CD34-positive selection [J].
Grimaz, S ;
Damiani, D ;
Michieli, M ;
Patriarca, F ;
Masolini, P ;
Baccarani, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (02) :567-567
[9]   CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma:: tumour cell contamination and outcome [J].
Gupta, D ;
Bybee, A ;
Cooke, F ;
Giles, C ;
Davis, JG ;
McDonald, C ;
Armitage, SE ;
McGuigan, D ;
Lyttelton, MPA ;
Kanfer, EJ ;
Apperley, JF ;
Samson, D .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (01) :166-177
[10]   Defective T-helper cell function after T-cell-depleting therapy affecting naive and memory populations [J].
Heitger, A ;
Winklehner, P ;
Obexer, P ;
Eder, J ;
Zelle-Rieser, C ;
Kropshofer, G ;
Thumher, M ;
Holter, W .
BLOOD, 2002, 99 (11) :4053-4062